Fna bx w/fluor gdn 1st les
CPT 10007 covers a fine needle aspiration (FNA) biopsy of the first lesion performed under fluoroscopic (real-time X-ray) guidance, where a thin needle removes tissue samples for testing. This is a minimally invasive diagnostic procedure used to determine if a mass or lesion is cancerous or benign.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always verify place of service coding—POS 22 (outpatient hospital) triggers the facility rate of $86.04 while POS 11 (office) supports the non-facility rate of $294.03
Impact: $207.99 payment difference (242% higher in non-facility setting)
Document and save all fluoroscopic images with the permanent medical record; at minimum, save representative images showing needle placement and target lesion visualization
Impact: Prevents downcoding to 10021 (palpation-guided FNA) which pays approximately $100-150 less, and protects against audit recoupment
Bill 10008, 10009, 10010, 10011, or 10012 for each additional lesion biopsied during the same session rather than multiple units of 10007
Impact: Using add-on codes ensures proper payment; billing multiple units of 10007 will result in denial or 50% reduction
Separately report imaging guidance with the appropriate radiology supervision and interpretation code only when distinct from the included fluoroscopic guidance
Impact: Fluoroscopy is bundled into 10007; billing 77002 separately will result in denial as a component of the primary procedure
Document the specific medical necessity for fluoroscopic guidance rather than ultrasound or CT guidance, including lesion location, depth, and visibility factors
Impact: Prevents payer challenges questioning modality choice and supports medical necessity if alternative guidance codes are queried
When pathology results are insufficient and repeat FNA is required, document why initial sample was inadequate and ensure separate date of service or use modifier 76 with strong documentation
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.